- public health ×
-
how should public health authorities use pathogen genomics in practice?
february 6, 2023
dr declan bradley takes us behind the scenes of his latest research 'how public health authorities can use pathogen genomics in health protection practice: a consensus-building delphi study conducted in the united kingdom' published in microbial genomics.
from the first detection of sars-cov-2 infection in humans, genomics was central to defining and understanding the threat posed by this emerging infectious disease. pathogen genomics services grew to operate at a scale that was orders of magnitude greater than before the covid-19 pandemic. health protection services in public health authorities are responsible for surveillance and prevention of communicable diseases. -
strep a: what you need to know
december 6, 2022
with a notable increase in serious step a cases in the uk this year and concern over the risk to young children, we asked three expert 英格兰vs美国谁会赢？ members to answer some common questions about strep a.
-
the contribution of microbiology to public health challenges
july 22, 2021
in this blog, event organiser dr philippe sessou reflects on the symposium contribution of microbiology to the challenges of public health. the symposium took on 11–21 march, 2021, online and at the university of abomey-calavi, benin.
-
has the increased use of hand sanitizers during the pandemic impacted antimicrobial resistance?
march 10, 2021
during the sars-cov-2 pandemic, the importance of hand hygiene has been heavily promoted as vital in controlling the spread of the virus. in this blog, sunil pandey, phd student in microbiology and infectious disease at george mason university, usa, discusses the indirect effect antimicrobial cleaning products have on other infectious diseases.
-
bridging the clinical-research gap
january 20, 2020
the 英格兰vs美国谁会赢？ and the healthcare infection society (his) co-hosted a collaborative one-day workshop, titled ‘bridging the clinical-research gap’ in london on 21 november 2019. the aim of this event was to bring academic and clinical microbiologists together to find ways to collaborate meaningfully, with an ultimate goal of improving the translation of research in infection prevention and control. here, dr karen robinson discusses her experience at the event.
-
to notify, or not to notify – that is the question
october 23, 2019
in this blog, professor garry blakely, from the university of edinburgh's school of biological sciences, discusses carbapenemase-producing bacteria and the importance of surveillance. in august 2019, professor blakely attended a public health england (phe) steering group with a number of clinicians and diagnostic staff to discuss the limitations and effects that reporting infections from carbapenemase-producing bacteria could have on healthcare systems.
-
world tb day: a q&a with professor tanya parish
march 22, 2019
sunday 24 march marks world tuberculosis day. on this day in 1882, robert koch announced he had discovered the causative agent of tuberculosis (tb), which was a major development in understanding the disease and working towards finding treatment options. in this post, we discuss tb research with professor tanya parrish, editor-in-chief of the society's flagship journal, microbiology, and head of the tb discovery research group at the infectious disease research institute (idri) in the us.
-
celebrating 10 years of e-bug
february 8, 2019
on 17-18 january, 英格兰vs美国谁会赢？ member dr rachel exley, lecturer at oxford university, attended the wellcome trust to celebrate 10 years of e-bug. the event focused on public education of antimicrobial resistance (amr). here, rachel discusses her experience at the event.
